---
phase: 18-reverse-parity-strengths-sweep
status: passed
verified: 2026-08-15
requirements: [GAP-03]
plans: ["18-01"]
must_haves_verified: 3
must_haves_total: 3
audit_only: true
---

# Phase 18 — Reverse-Parity Strengths Sweep · Verification

**Verdict: PASSED** — 3/3 ROADMAP success criteria satisfied; GAP-03 delivered. Audit-only: zero `fdars-core/src/` edits.

**Deliverable:** `.planning/research/R-AUDIT-REPORT.md` §Phase 18 (lines 1022–1137), appended after Phase 17; archived scikit-fda `AUDIT-REPORT.md` untouched.

## Success Criteria

| # | Criterion | Verdict | Evidence |
|---|-----------|---------|----------|
| SC1 | Catalogues fdars capabilities with no R equivalent (closest-R "none found" per row) | ✅ | §Reverse-Parity — fdars-unique: 6 rows (U-1…U-6), each with fdars module + closest-R search; headliners U-3 explainability, U-5 streaming depth. |
| SC2 | Lists where fdars leads its closest R analog (R analog named + lead stated) | ✅ | §Reverse-Parity — fdars-ahead: 6 rows (A-1…A-7, A-3 deliberately skipped as a Phase-17 gap), each naming the R analog + the lead. |
| SC3 | Derived from a full module-map walk (per-module coverage documented) | ✅ | Per-Module Coverage table covers all 42 module units of `fdars-core/src/` with per-unit verdicts (67 table rows in the section). |

## Integrity checks

- **R-honesty enforced:** v0.14.0 scikit-fda strengths re-vetted against R; casualties (SPM/conformal/elastic/SSA/FoF) documented rather than falsely claimed — 30 → 12 R-honest strengths. ✅
- Zero `fdars-core/src/` edits; Phases 16/17 sections + scikit-fda `AUDIT-REPORT.md` unmodified. ✅
- Honest completeness flag: `Rfssa` (functional SSA, not in Phase-16 survey) recorded as a re-vet casualty, not hidden. ✅

## Notes

- Executed by a module-walk agent (opus); verified independently. Nyquist VALIDATION.md not applicable (audit phase).
- Carry-forward to Phase 19: note the `Rfssa` Phase-16 inventory-completeness caveat in the consolidated report.
